Johnson & Johnson (JNJ) Debt to Equity (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Debt to Equity data on file, last reported at $0.68 in Q1 2026.

• Quarterly Debt to Equity rose 1.25% year-over-year to $0.68 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.68 (up 1.25% YoY) and the FY2025 annual result came in at $0.59, up 14.71% from the prior year.
• Debt to Equity climbed to $0.68 in Q1 2026 per JNJ's latest filing, from $0.59 in the prior quarter.
• The five-year high for Debt to Equity was $0.75 in Q2 2023, with the low at $0.42 in Q4 2023.
• Average Debt to Equity over 5 years is $0.54, with a median of $0.51 recorded in 2024.
• Year-over-year, Debt to Equity jumped 68.26% in 2023 and plunged 35.66% in 2024.
• Johnson & Johnson's Debt to Equity stood at $0.43 in 2022, then declined by 0.66% to $0.43 in 2023, then gained by 20.15% to $0.51 in 2024, then advanced by 14.71% to $0.59 in 2025, then grew by 15.22% to $0.68 in 2026.
• Business Quant data shows JNJ's Debt to Equity at $0.68 in Q1 2026, $0.59 in Q4 2025, and $0.58 in Q3 2025.